A review on the efficacy and safety of gabapentin in the treatment of chronic cough

Expert Opinion on Pharmacotherapy

Volumn 16, Issue 1, 2015, Pages 135-145

  Ryan, Nicole M ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Central sensitization; Chronic cough; Gabapentin; Sensory laryngeal neuropathy; Toxicity

Indexed keywords

GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; ANTITUSSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

CHRONIC COUGH; DISEASE ASSOCIATION; DIZZINESS; DRESS SYNDROME; DRUG EFFICACY; DRUG INTOXICATION; DRUG MECHANISM; DRUG SAFETY; FATIGUE; GAIT DISORDER; GAIT DISTURBANCE; HUMAN; HYPERSENSITIVITY; LARYNGEAL HYPERSENSITIVITY; MEDLINE; META ANALYSIS; NAUSEA; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSORY NEUROPATHY; SOMNOLENCE; SYSTEMATIC REVIEW; CHRONIC DISEASE; COUGH; NEURALGIA, POSTHERPETIC; PATHOPHYSIOLOGY;

AMINES; ANTITUSSIVE AGENTS; CHRONIC DISEASE; COUGH; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84917706829     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2015.981524     Document Type: Review

References (71)

1. Gibson PG, Ryan NM. Cough pharmacotherapy: current and future status. Expert Opin Pharmacother 2011;12(11):1745-55
2. Ryan NM, Gibson PG. Recent additions in the treatment of cough. J Thorac Dis 2014;6(S7):S739-47
3. Cobeta I, Pacheco A, Mora E. The role of the larynx in chronic cough. Acta Otorrinolaringol Esp 2013;64(5):363-8
4. Pacheco A, Cobeta I. Refractory chronic cough, or the need to focus on the relationship between the larynx and the esophagus. Cough 2013;9(1):10
5. Canning BJ. Afferent nerves regulating the cough reflex: mechanisms and mediators of cough in disease. Otolaryngol Clin North Am 2010;43(1):15-25, vii
6. Altman KW, Simpson CB, Amin MR, et al. Cough and paradoxical vocal fold motion. Otolaryngol Head Neck Surg 2002;127(6):501-11
7. Widdicombe JG. Afferent receptors in the airways and cough. Respir Physiol 1998;114(1):5-15
8. Canning BJ. Functional implications of the multiple afferent pathways regulating cough. Pulm Pharmacol Ther 2011;24(3):295-9
9. Groneberg DA, Niimi A, Dinh QT, et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 2004;170(12):1276-80
10. Seki N, Shirasaki H, Kikuchi M, et al. Expression and localization of TRPV1 in human nasal mucosa. Rhinology 2006;44(2):128-34
11. Watanabe N, Horie S, Michael GJ, et al. Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm Pharmacol Ther 2005;18(3):187-97
12. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):1S-23S
13. Bastian RW, Vaidya AM, Delsupehe KG. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg 2006;135(1):17-21
14. Chung KF, McGarvey L, Mazzone SB. Chronic cough as a neuropathic disorder. Lancet Respir Med 2013;1(5):414-22
15. Cohen SM, Misono S. Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. Otolaryngol Head Neck Surg 2013;148(3):374-82
16. Cukier-Blaj S, Bewley A, Aviv JE, Murry T. Paradoxical vocal fold motion: a sensory-motor laryngeal disorder. Laryngoscope 2008;118(2):367-70
17. Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 2005;114(4):253-7
18. Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med 2006;119(5):e13-15
19. Murry T, Branski RC, Yu K, et al. Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder. Laryngoscope 2010;120(8):1576-81
20. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebocontrolled trial. Lancet 2012;380(9853):1583-9
21. Vertigan AE, Gibson PG. Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers. J Voice 2011;25(5):596-601
22. Gracely RH, Undem BJ, Banzett RB. Cough, pain and dyspnoea: similarities and differences. Pulm Pharmacol Ther 2007;20(4):433-7
23. Mazzone SB, Mori N, Canning BJ. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J Physiol 2005;569(Pt 2):559-73
24. Spring PJ, Kok C, Nicholson GA, et al. Autosomal dominant hereditary sensory neuropathy with chronic cough and gastro-oesophageal reflux: clinical features in two families linked to chromosome 3p22-p24. Brain 2005;128(Pt 12):2797-810
25. Barros P, Morais H, Santos C, et al. Clinical and neurophysiologic characterization of an European family with hereditary sensory neuropathy, paroxysmal cough and gastroesophageal reflux. Arq Neuropsiquiatr 2014;72(4):269-72
26. Pacheco A, Cobeta I, Wagner C. Refractory chronic cough: new perspectives in diagnosis and treatment. Arch Bronconeumol 2013;49(04):151-7
27. Ryan NM, Gibson PG. Characterization of laryngeal dysfunction in chronic persistent cough. Laryngoscope 2009;119(4):640-5
28. Murry T, Tabaee A, Owczarzak V, Aviv JE. Respiratory retraining therapy and management of laryngopharyngeal reflux in the treatment of patients with cough and paradoxical vocal fold movement disorder. Ann Otol Rhinol Laryngol 2006;115(10):754-8
29. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006;61(12):1065-9
30. Morice AH. The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung 2010;188(Suppl 1):S87-90
31. Birring SS. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med 2011;183(6):708-15
32. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007;29(6):1256-76
33. Kimos P, Biggs C, Mah J, et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain 2007;127(1-2):151-60
34. Kilic FS, Sirmagul B, Yildirim E, et al. Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies. Indian J Med Res 2012;135(5):630-5
35. FDA. Suicidal Behavior and Ideation and Antiepileptic Drugs [Internet]. 2009. Available from: http://www.fda. gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformation forPatientsandProviders/ucm1000190. htm [Lase accessed 26 Augest 2014]
36. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009;122(10 Suppl):S22-32
37. Moore RA, Wiffen PJ, Derry S, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;4:CD007938
38. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123(4 Pt 1):413-17
39. McGarvey LP, Heaney LG, Lawson JT, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998;53(9):738-43
40. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA 2004;291(5):605-14
41. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001;17(4):284-95
42. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl):S105-20
43. Norris BK, Schweinfurth JM. Management of recurrent laryngeal sensory neuropathic symptoms. Ann Otol Rhinol Laryngol 2010;119(3):188-91
44. Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ. A cohort description and analysis of the effect of gabapentin on idiopathic cough. Cough 2012;8(1):9
45. Greene SM, Simpson CB. Evidence for sensory neuropathy and pharmacologic management. Otolaryngol Clin North Am 2010;43(1):67-72, viii
46. Amin MR, Koufman JA. Vagal neuropathy after upper respiratory infection: a viral etiology? Am J Otolaryngol 2001;22(4):251-6
47. Mackenzie AM. Gabapentin for refractory chronic cough. Thorax 2013. [Epub ahead of print]
48. Fan H, Yu W, Zhang Q, et al. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials. J Clin Pharm Ther 2014;39(4):334-42
49. Irving G, Jensen M, Cramer M, et al. Efficacy and tolerability of gastricretentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebocontrolled clinical trial. Clin J Pain 2009;25(3):185-92
50. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94(2):215-24
51. Sang CN, Sathyanarayana R, Sweeney M. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain 2013;29(4):281-8
52. Zhang L, Rainka M, Freeman R, et al. A randomized, double-blind, placebocontrolled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748). J Pain 2013;14(6):590-603
53. Wallace MS, Irving G, Cowles VE. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Investig 2010;30(11):765-76
54. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003;25(1):81-104
55. Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B. Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol 2003;41(1):11-15
56. Fernandez MC, Walter FG, Petersen LR, Walkotte SM. Gabapentin, valproic acid, and ethanol intoxication: elevated blood levels with mild clinical effects. J Toxicol Clin Toxicol 1996;34(4):437-9
57. Fischer JH, Barr AN, Rogers SL, et al. Lack of serious toxicity following gabapentin overdose. Neurology 1994;44(5):982-3
58. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2002;20(5):391-452
59. Verma A, St Clair EW, Radtke RA. A case of sustained massive gabapentin overdose without serious side effects. Ther Drug Monit 1999;21(6):615-17
60. Prasa D, Uwe S, Hoffman-Walbeck P, et al. Gabapentin overdose: a case series. Clin Toxicol 2014;52:331
61. Häkkinen M, Vuori E, Kalso E, et al. Pregabalin and gabapentin abuse and toxicity as disclosed from postmortem cases. Clin Toxicol 2014;52:329
62. Grosshans M, Lemenager T, Vollmert C, et al. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 2013;69(12):2021-5
63. Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res 2013;36(3):237-51
64. Mazzone SB, Reynolds SM, Mori N, et al. Selective expression of a sodium pump isozyme by cough receptors and evidence for its essential role in regulating cough. J Neurosci 2009;29(43):13662-71
65. Governo RJ, Morris PG, Marsden CA, Chapman V. Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study. Br J Pharmacol 2008;153(7):1558-67
66. Mazzone SB, McLennan L, McGovern AE, et al. Representation of capsaicin-evoked urge-to-cough in the human brain using functional magnetic resonance imaging. Am J Respir Crit Care Med 2007;176(4):327-32
67. Widdicombe J, Eccles R, Fontana G. Supramedullary influences on cough. Respir Physiol Neurobiol 2006;152(3):320-8
68. Adcock JJ. TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther 2009;22(2):65-70
69. Wiffen PJ, Derry S, Moore RA, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev 2013;11:CD010567
70. Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 2006;6(1):108-13
71. Spina D, Page CP. Regulating cough through modulation of sensory nerve function in the airways. Pulm Pharmacol Ther 2013;26(5):486-90